414 related articles for article (PubMed ID: 24630539)
21. Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study.
Miyakawa A; Shibamoto Y; Baba F; Manabe Y; Murai T; Sugie C; Yanagi T; Takaoka T
Radiat Oncol; 2017 Sep; 12(1):152. PubMed ID: 28893300
[TBL] [Abstract][Full Text] [Related]
22. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
[TBL] [Abstract][Full Text] [Related]
23. Using max standardized uptake value from positron emission tomography to assess tumor responses after lung stereotactic body radiotherapy for different prescriptions.
Ding M; Zollinger W; Ebeling R; Heard D; Posey R
J Appl Clin Med Phys; 2018 Nov; 19(6):226-233. PubMed ID: 30216639
[TBL] [Abstract][Full Text] [Related]
24. Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
Mangona VS; Aneese AM; Marina O; Hymas RV; Ionascu D; Robertson JM; Gallardo LJ; Grills IS
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):124-32. PubMed ID: 25442337
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.
Katoh N; Soda I; Tamamura H; Takahashi S; Uchinami Y; Ishiyama H; Ota K; Inoue T; Onimaru R; Shibuya K; Hayakawa K; Shirato H
Radiat Oncol; 2017 Jan; 12(1):3. PubMed ID: 28057036
[TBL] [Abstract][Full Text] [Related]
27. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
[TBL] [Abstract][Full Text] [Related]
28. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.
Sonke JJ; Rossi M; Wolthaus J; van Herk M; Damen E; Belderbos J
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):567-74. PubMed ID: 19046825
[TBL] [Abstract][Full Text] [Related]
29. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of local control and disease free survival in centrally located non-small cell lung cancer treated with stereotactic body radiation therapy.
Duijm M; van der Voort van Zyp NC; Granton PV; van de Vaart P; Mast ME; Oomen-de Hoop E; Hoogeman MS; Nuyttens JJ
Acta Oncol; 2020 Jul; 59(7):809-817. PubMed ID: 32286140
[No Abstract] [Full Text] [Related]
31. Mid-ventilation based PTV margins in Stereotactic Body Radiotherapy (SBRT): a clinical evaluation.
Peulen H; Belderbos J; Rossi M; Sonke JJ
Radiother Oncol; 2014 Mar; 110(3):511-6. PubMed ID: 24560765
[TBL] [Abstract][Full Text] [Related]
32. Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates.
Yamashita H; Haga A; Takahashi W; Takenaka R; Imae T; Takenaka S; Nakagawa K
Radiat Oncol; 2014 Nov; 9():243. PubMed ID: 25385062
[TBL] [Abstract][Full Text] [Related]
33. Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors.
Parker SM; Siochi RA; Wen S; Mattes MD
Pract Radiat Oncol; 2019 Jan; 9(1):e90-e97. PubMed ID: 30267899
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
[TBL] [Abstract][Full Text] [Related]
35. Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases.
Swaminath A; Massey C; Brierley JD; Dinniwell R; Wong R; Kim JJ; Velec M; Brock KK; Dawson LA
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):639-48. PubMed ID: 26461006
[TBL] [Abstract][Full Text] [Related]
36. An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.
Duffton A; Harrow S; Lamb C; McJury M
Br J Radiol; 2016 Jun; 89(1062):20150492. PubMed ID: 27052681
[TBL] [Abstract][Full Text] [Related]
37. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
[TBL] [Abstract][Full Text] [Related]
38. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
[TBL] [Abstract][Full Text] [Related]
39. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution's experience.
Chai G; Yin Y; Zhou X; Hu Q; Lv B; Li Z; Shi M; Zhao L
Transl Lung Cancer Res; 2020 Aug; 9(4):1496-1506. PubMed ID: 32953521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]